03 Nov South Africa’s Aspen signs vaccine deal with Johnson & Johnson
South African pharmaceutical firm Aspen has signed an agreement with Johnson & Johnson (J&J) to manufacture a COVID-19 vaccine following the completion of clinical trials. The vaccine will be manufactured at Aspen’s R3 billion new sterile facility in Port Elizabeth, which has the capacity to manufacture...